Tuesday, January 10, 2012

White Paper - Envisioning a New Commercial Model: Is it Right for Your Brand

As the pace and scope of change within the healthcare life sciences continue to increase, many are questioning the validity of traditional "fundamentals" of the life sciences commercialization model for connecting brands with healthcare professionals, consumers, and economic customers. In this PharmaVoice digital feature, Will Reese and Steve Wray of Cadient Group analyze the core issues for life sciences commercial stakeholders facing the challenges of an ever-changing environment.

For more information about Cadient, visit http://www.cadient.com/.

Download Whitepaper
See All PharmaVOICE whitepapers

Wednesday, January 4, 2012

White Paper - Large Pharma & Healthcare Company Uses Aravo for Due Diligence on FCPA Compliance and Critical Lifecycle Management Automation

A large pharmaceutical company faced a serious potential problem with FCPA compliance and partner due diligence processes. Through creation of a rigorous best practice FCPA program, the company was able to significantly mitigate their exposure through execution of an enhanced compliance plan.

For more information about Aravo, visit
www.aravo.com.

Download Whitepaper
See All PharmaVOICE whitepapers

Download Companion Podcast - Automating Pharma FCPA Due Diligence

Download Podcast Transcript (PDF)

Podcast: Automating Pharma FCPA Due Diligence

In this episode, Mr. Shecterle discusses FCPA Compliance and anti-bribery practices at large pharmaceutical and life sciences companies.

For more information about Aravo, visit
www.aravo.com.

Download Podcast

Download Podcast Transcript (PDF)

See All PharmaVOICE podcasts

Download Companion Whitepaper - Large Pharma & Healthcare Company Uses Aravo for Due Diligence on FCPA Compliance and Critical Lifecycle Management Automation

White Paper - Shifting Pharma Sales Models to Focus on Providing Value


Sales models are adapting to include new "channels", such as tele-detailing, e-detailing, and web advertising to physicians. The primary channel to date has been live in-office interactions with sales representatives. What are needed are complementary secondary channels that are available 24/7 and on-demand.

For more information about PhoneScreen, visit www.phonescreen.com.

Download Whitepaper

See All PharmaVOICE whitepapers

Download Companion Podcast - Tele-detailing: Responding to Changing Pharma Sales Models 

Download Podcast Transcript (PDF)

PhoneScreen is an AMAC company

Podcast: Tele-detailing: Responding to Changing Pharma Sales Models

In this episode, Mr. Shapiro talks about the challenges life science companies face when providing information on their products to physicians and healthcare providers.

For more information about PhoneScreen, visit
www.phonescreen.com.

Download Podcast

Download Podcast Transcript (PDF)

See All PharmaVOICE podcasts

Download Companion Whitepaper - Shifting Pharma Sales Models to Focus on Providing Value

Podcast: The C-Suite: How Biotech Improves the Standard of Care of Patients

In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSIN® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs.

For more information about Oncolytics Biotech, visit http://www.oncolyticsbiotech.com/.

Download podcast

White Paper - Identifying Strategic Partners for Product Development

Developing strategic partnerships to fill product markets and niches is a critical undertaking. An often overlooked opportunity lies in clinical and academic institutions, many who have robust early-stage research programs and a significant desire to collaborate with commercial organizations.

For more information about Snowfish, visit http://www.snowfish.com/.

Download whitepaper

Tuesday, January 3, 2012

White Paper - Taming the Social Networking Giant

This deck of webinar slides contains the results of a study of over 1,400 U.S. consumers and their use of social media. Healthcare can use these findings to better connect with consumers using social media.

For more information about SSI, visit www.surveysolutions.com.

Download Whitepaper - Taming the Social Networking Giant

See All PharmaVOICE whitepapers

Download Companion Podcast

Download Podcast Transcript (PDF)

Podcast: Understanding How Social Networks Drive Healthcare Decisions: Mapping a New "Influence" Landscape

In this episode, Mr. DeAngelis discusses a variety of issues regarding consumers' usage of social media for healthcare information. You'll learn some of the results of a study of over 1,400 U.S. consumers participating in proprietary panels and web communities.

For more information about SSI, visit
www.surveysolutions.com.

Download Podcast

Download Podcast Transcript (PDF)

See All PharmaVOICE podcasts

Download Companion Whitepaper - Taming the Social Networking Giant